Health Care Capital Forum presented by Long Island Capital Alliance

Long Island Capital Alliance LogoLong Island Capital Alliance & Stony Brook University CEWIT and Sensor CAT present HEALTH CARE CAPITAL FORUM featuring 6 Emerging Growth Companies & Industry Investor Panel on Friday, March 8th, 8:00am – 10:30am

Presenting Companies

AdhereTech has created patented smart pill bottles that increase medication adherence. These bottles measure the exact number of pills or liquid in the bottle in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via phone call or text.

CytoSorbents Corporation is a critical care-focused therapeutics company using blood purification filters to control excessive, potentially deadly inflammation that could otherwise cause the failure of vital organs.

First Wave Technologies Inc. is a medical device facilitation business, with two initial products, the First Crush automated pill crusher in order to make them digestible due to the high demand by the growing population of senior citizens; and a respiratory device conversion and amplification technology that turns a ventilator into the equivalent of a $150,000 anesthesia machine.

Mobile Health One, Inc. develops mobile, on-demand HIPAA-compliant systems that unify healthcare professionals within and between organizations by simplifying communications to accelerate, consolidate, and control information sharing.

Raland Therapeutics, Inc. has developed diagnostic and therapeutic devices that use implantable biosensors to provide real time, in-vivo monitoring of biological signaling and cellular responses while minimizing animal handling, labor requirements, cell culture/pathologic processing and capital costs. 

Venus Pharmaceuticals International, Inc., a well-established pharmaceuticals manufacturer, has developed a proprietary photo-bioreactor technology to grow, harvest, and dry/extract micro-algae indoors, which is extremely useful for its medicinal properties.

About Long Island Capital Alliance Capital Forums

The capital forum provides an opportunity to meet capital providers and businesses seeking capital, as well as to hear a panel of industry experts discuss financing alternatives for health care businesses.

Learn more and register >

Long Island Capital Alliance

Long Island Capital Alliance LogoSince 1984, the Long Island Capital Alliance (LICA), formerly known as Long Island Venture Group, has been promoting business growth on Long Island.

LICA seeks to create a productive and business-friendly environment that will afford area businesses access to the resources necessary to compete successfully in today’s markets. LICA serves as a focal point for the exchange of ideas among new and existing business enterprises, successful entrepreneurs, investors, and service providers. Through quarterly capital forums and special meetings, LICA brings together members of the region’s business community.

Learn more about the Long Island Capital Alliance.

LICA Healthcare Capital Forum Applications Open

Long Island Capital Alliance Logo

Applications are being accepted for presenting companies for Healthcare Capital Forum to be held March 8, 2013 in Melville, New York presented by the Long Island Capital Alliance.

Applicants should be:

  • Involved in the healthcare services, technology or devices
  • Seeking growth or expansion capital or a private equity investment

If selected, you will have an opportunity to make an 8-minute presentation to a group of investors, venture capitalists, private equity firms, investment bankers, lenders, and others.

Application Deadline is January 28, 2013

To apply, please  submit your executive summary via the Long Island Capital Alliance presenting company application.

BioEntrepreneur‐In‐Residence (B‐EIR) Call for Applications at Stony Brook University

Stony Brook UniversityThe Center for Biotechnology (CFB) is seeking one or more highly‐motivated and experienced BioEntrepreneur(s)‐In‐Residence (B‐EIR) to launch new bioscience ventures in the Long Island region based upon commercially promising biomedical technologies emerging from Stony Brook University. The B‐EIR(s) will be responsible for the identification and evaluation of intellectual property available for license from a pre‐ screened pool of start‐up opportunities. The B‐EIR will engage directly with inventors and CFB senior staff members to determine and outline critical technical milestones to add‐value and mitigate the risk of early stage technology commercialization. The B‐EIR will ultimately select specific biomedical technologies to form the basis of one or more new companies, and will be required to develop detailed commercialization strategies, business plans and investor presentations. The B‐EIR will also (a) negotiate and execute option and/or license agreements with the Office of Technology Licensing and Industry Relations (OTLIR) as may be appropriate, (b) seek and secure capital from both public and private sources, and (c) exit from the B‐EIR program to lead the start‐up company which must be located in the Long Island region.

To help facilitate this process the CFB will:

  • Compensate the B‐EIR(s) as an independent consultant during the due diligence and technology development process,
  • Provide a modest budget for critical experiments, technology assessment and/or analysis, 
  • Facilitate access to faculty expertise and core research facilities, business incubator facilities, and business support services as needed,
  • Provide senior business development and technology commercialization staff support, as well as the support of MBA, PhD, and JD student teams to assist with market and IP assessments, competitive analyses, and financial modeling,
  • Assist with introductions to the Long Island Angel Network (LIAN), Long Island Capital Alliance (LICA), and other Angel and Venture Capital groups.

The successful B‐EIR candidate will possess domain expertise and technical proficiency in the life sciences, as well as business acumen and industry experience, particularly in early‐stage technology commercialization, new venture creation, and fundraising. Advanced degree in a life sciences field, business and/or law are preferred. Compensation and term of engagement dependent upon percentage effort, experience, and the specific start‐up opportunity selected. B‐EIRs will report to the CFB and its Advisory Board (see below). Interested parties should reply to Diane Fabel (diane.fabel@stonybrook.edu ), B‐EIR Search Committee, with a statement of interest and resume. Inquiries will be considered through September 30th, or until appropriate candidates are identified.

Advisory Board

  • Colin Goddard, PhD, Chairman, CEO, Coferon
  • Leah Lipsich, PhD, Executive Director, Regeneron Pharmaceuticals
  • Glenn D. Prestwich, PhD, Presidential Chair, Medicinal Chemistry, University of Utah Andrew A. Protter, PhD, VP Preclinical Development, Medivation
  • Clinton T. Rubin, PhD, Chairman, Biomedical Engineering, Stony Brook University Charles S. Ryan, JD, PhD, Senior VP & Chief Patent Counsel, Forest Laboratories

Presenters Selected for Cyber Security Capital Forum

Asking for MoneyWe just got word on the presenters for the upcoming Cyber Security Capital Forum on Friday, September 14th, 8am – 10:30am. The event is co-hosted by LICA, LIFT and LISTnet. 

The capital forum provides an opportunity to meet capital providers and businesses seeking capital, as well as to hear a panel of industry experts discuss financing alternatives for cyber security businesses. Learn more about this event.

Presentors

IP Video Corporation

Its C3Fusion product allows users to securely integrate multi-platform video and audio inputs and prioritize threats from static and mobile locations.

Mobile Data Systems

Mobile Data Systems’ patent-pending FadeMark anti-counterfeit technology solution provides a secure interoperable wireless scanning system to identify and eliminate counterfeiting, theft and fraud.

Secure Decisions

Secure Decisions provides visual analytic tools to help identify risks posed by mobile computing devices. Wireless data and geographic information system are integrated to provide a unified view of detected wireless devices, their vulnerabilities, and threats.

Strategic Security Resources

Strategic Security Resources provides risk assessment and resource allocation strategies to identify and prioritize risk, and to develop high-risk reduction solutions.

Wiznucleus

Wiznucleus has proprietary software that protects nuclear power plants and other critical facilities from cyber hackers.

Industry Investor Panelists

Russell M. Artzt

Co-founder and former Chairman of CA Inc. (NASDAQ: CA) (formerly, Computer Associates International Inc.) Mr. Artzt led CA’s eTrust security brand, and was responsible for all aspects of CA’s award-winning eTrust security product line. With more than 30 years experience in the IT industry as atechnology leader, consultant and executive, in March 2008 he was inducted into the Long Island Technology Hall of Fame.

Robert Brill

Founding Managing Partner of Newlight Management and was previously a General Partner of PolyVentures, venture capital funds whose principal investment focus was on early stage investments in technology companies. Before joining PolyVentures, Mr. Brill was a successful “turn around” CEO at two technology companies.

James McIlree

Equity research analyst at New York-based investment bank Dominick & Dominick. Mr. McLlree has close to 25 years experience in the investment business, as a sell-side research analyst and buy-side analyst and portfolio manager, primarily focusing on emerging growth companies in the defense electronics markets.

William Reinisch

 Mr. Reinisch is a Partner of Palladin Capital Group, a private equity firm with a proven track record of financial expertise, national security experience and specialized technical competence.

 

Funding Opportunity: Cyber Security Capital Forum

Cyber SecurityThe Long Island Capital Alliance (“LICA”), announced that it will be holding a Cyber Security Capital Forum on September 14.  The capital forum will be held in partnership with the Long Island Software & Technology Network (“LISTnet”) and the Long Island Forum for Technology (“LIFT”).   LISTnet and LIFT will facilitate LICA’s reach into the rapidly evolving and critically important field of cyber security. 

At the capital forum, up to 5 cyber security companies will showcase their technologies and services. A panel of investors, business executives, and industry experts will observe these presentations and provide their insights on the development of the cyber security industry and its investments prospects. 

Applicants should be seeking growth or expansion capital and possess a unique cyber security technology or address a need in the industry.  If selected, they will have an opportunity to make an 8-minute presentation to a group of investors, venture capitalists, investment bankers, lenders, and others. To apply, please e-mail an executive summary or business plan to Amanda Seelmann (516-328-2300 x211) at aseelmann@abramslaw.com or submit it through www.licapital.org.

Technology Transfer Capital Forum on June 8, 2012

Melville, NY – May 17, 2012 – The Long Island Capital Alliance (“LICA”), the leading non-profit capital formation and business development organization serving regional companies, today announced the presenting companies and panelists for its Technology Transfer Capital Forum to be held on June 8, 2012.  The event is being conducted in furtherance of an alliance between LICA and Brookhaven National Laboratory (BNL), a world-leading research institution.  The Technology Transfer Capital Forum is being held in an effort to facilitate the formation and acceleration of high-growth businesses on Long Island, based on technologies developed at BNL.

LICA and BNL are hosting the Technology Transfer Capital Forum on June 8, 2012, at 8 a.m. at 68 South Service Road, Melville, NY.  The technology companies and the exciting technologies being presented at the forum have been developed through BNL research.  Three presenting companies seek capital investments for furtherance of their business plans, while two of the technologies being highlighted are immediately available for the creation of new businesses or to enhance the development of existing companies.

For more information or to attend the event, please contact LICA today or register online

Panel of Industry Experts

David L. Calone: CEO of Jove Equity Partners LLC, a venture capital firm which invests in the internet, software, digital media, energy, real estate, and health care industries.

William J. Catacosinos: Managing Partner of Laurel Hill Capital Partners LLC, an investment management company organized to acquire, develop, and manage investment opportunities. Former Chairman and CEO of Long Island Lighting Company (LILCO). 

John Maroney: Vice President, Office of Technology Transfer, Cold Spring Harbor Laboratory, which has executed a highly successful technology transfer program.

Steve Winick: Principal of Topspin Partners, LP, one of Long Island’s leading venture capital funds, which began investing in 1995. The firm is an affiliate of Renaissance Technologies, a well-known hedge fund.

Presenting Companies and Technologies

Hybridyne Imaging Technologies, Inc.: Hybridyne solves the problem of reliably detecting small-scale, early stage prostate cancer by using a new compact digital gamma camera combined with commercially available radiopharmaceuticals for high-resolution localization and imaging of malignant prostate tumors without the need for multiple, potentially harmful invasive biopsies. Wow Factor: With a widespread need to detect early-stage cancer through high-resolution, targeted nuclear imagery, their compact gamma camera technology is providing a breakthrough capability that is bringing early stage cancer diagnosis to an unprecedented level of sophistication.

NextRay, Inc.: Bringing breakthrough high-resolution, low-dose medical imaging technique from the synchrotron to the doctor’s office. Wow Factor: Produces more detailed images with less than one percent of the radiation used in current X-ray imaging systems. 

New Technology for Lithium Ion Battery Electrodes: This technology will create more powerful lithium ion batteries, which are key components of portable consumer electronic devices, electric vehicles, and grid-scale energy storage systems.  Wow Factor: Batteries with this technology have been show to have more energy efficiency and longer lifetime than current lithium ion batteries.

High Performance Room-Temperature Radiation Detector: These compact cadmium zinc telluride (CZT) detectors can identify elemental isotopes and perform high-spatial-resolution digital imaging. The ability to operate at room temperature makes these high-performance CZT detectors more practical in many applications and cost-effective compared to existing detectors that require an expensive cooling apparatus for handling liquid nitrogen. Increased charge collection efficiency and higher energy resolution offered by the unique BNL CZT detector design enables the use of commercially available imperfect CZT crystals, supporting fabrication of a robust, low-cost detector system. Wow Factor:  The characteristics of these high performance CZT detectors make them ideal for deployment in spaces too small for conventional cryogenically-cooled detectors, impacting several medical, environmental, and national-security markets. Their characteristics also support fabrication of large-area detecting planes composed on individual tiles that can substitute for advanced, but more-expensive, monolithic 3D detectors.

SMES/Superconducting Magnet Energy Storage Technology: This superconductor-based energy storage technology uses powerful magnetic fields to store huge amounts of energy and connects these energy storage devices to the electric power grid. Wow Factor:  Uses superconducting cables that virtually eliminate power losses, which can revolutionize energy storage and transmission worldwide.

SynchroPET: Commercializing new positron emission tomography (PET) technology out of Brookhaven National Laboratory.  The company is currently working on four prototypes, two for pre-clinical research and drug development, and two for human diagnostics. All four devices can be considered disruptive technologies in their respective fields. Wow Factor: Impact creates detailed images and quantitative analysis for actionable knowledge in medical research and diagnostics through innovative scalable solutions.